Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University
Department of Medical Oncology, Second Affiliated Hospital of Naval Medical University
Shanghai, China1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Aim of This Study is to Assess the Efficacy and Safety of Chidamide, Regorafenib in Combination With Iparomlimab and Tuvonralimab for the Treatment of Advanced Colorectal Cancer in Third-line Therapy and Subsequent Lines. | Advanced Colorectal Cancer in the Third-line Treatment and Beyond; pMMR/MSS Advanced Colorectal Cancer | Recruiting | Phase 2 | 2025-04-16 | NCT06930118 |